HighVista Strategies’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-15,738
| Closed | -$569K | – | 165 |
|
|
2023
Q2 | $569K | Hold |
15,738
| – | – | 0.26% | 115 |
|
|
2023
Q1 | $585K | Buy |
15,738
+4,035
| +34% | +$150K | 0.48% | 68 |
|
|
2022
Q4 | $530K | Buy |
11,703
+892
| +8% | +$40.4K | 0.31% | 73 |
|
|
2022
Q3 | $755K | Sell |
10,811
-285
| -3% | -$19.9K | 0.43% | 62 |
|
|
2022
Q2 | $745K | Buy |
11,096
+1,343
| +14% | +$90.2K | 0.45% | 51 |
|
|
2022
Q1 | $802K | Buy |
9,753
+517
| +6% | +$42.5K | 0.51% | 59 |
|
|
2021
Q4 | $1.36M | Buy |
9,236
+747
| +9% | +$110K | 1.08% | 27 |
|
|
2021
Q3 | $1.5M | Buy |
8,489
+3,563
| +72% | +$630K | 0.99% | 19 |
|
|
2021
Q2 | $796K | Buy |
4,926
+660
| +15% | +$107K | 0.56% | 51 |
|
|
2021
Q1 | $731K | Buy |
4,266
+703
| +20% | +$120K | 0.54% | 35 |
|
|
2020
Q4 | $783K | Buy |
3,563
+163
| +5% | +$35.8K | 0.5% | 48 |
|
|
2020
Q3 | $565K | Sell |
3,400
-177
| -5% | -$29.4K | 0.41% | 32 |
|
|
2020
Q2 | $408K | Buy |
+3,577
| New | +$408K | 0.34% | 60 |
|